EUVIMEDEUVIMED entdecken
Crossref

Dihydromyricetin alleviates imiquimod-induced psoriasiform inflammation by inhibiting M1 macrophage polarization

Rao Li, Xingchen Zhou, Manyun Mao, Wangqing Chen, Wu Zhu, Xiang Chen

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-025-03905-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Rao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. Hauptthemen laut MEDLINE: Flavonols, Psoriasis, Macrophages, Anti-Inflammatory Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dihydromyricetin (DMY), a flavonoid, belongs to a class of natural compounds and possesses anti-inflammatory properties. The objective of this research is to investigate the effects and mechanism of DMY in mice induced by imiquimod (IMQ). Here, DMY ointment was topically applied to evaluate the effect of DMY on psoriasis, while the results showed DMY improved clinical phenotype of IMQ-induced psoriasiform dermatitis. Histological evaluation revealed decreases in keratinocyte hyperplasia and immune cell infiltration in mice after DMY administration. Besides, DMY treatment could attenuate psoriasiform inflammation as showed in the decreased expression of inflammation mediators such as IL-17a, IL-23a, TNF-α, IL-6, IL-1β, IL-12a, CXCL2, and S100A8 in the skin of mice. Mechanistically, DMY reduced the polarization of macrophages towards the pro-inflammatory M1 phenotype by inhibiting the TLR4/NF-κB pathway, importantly, which subsequently regulated the differentiation of T helper (Th) 1 and Th17 cell subsets, leading to the relief of immune inflammatory response in psoriasis. In conclusion, the research reveals that DMY markedly attenuated IMQ-induced psoriasis in mice and provides that DMY have great potential for treatment of psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonolsPsoriasisMacrophagesAnti-Inflammatory AgentsAnimalsImiquimodMiceDisease Models, AnimalTh17 CellsSkinToll-Like Receptor 4HumansSignal TransductionCytokinesNF-kappa BKeratinocytesTh1 Cells

Stichwörter der Autor:innen

DihydromyricetinMacrophagePsoriasisTLR4

Substanzen

ImiquimoddihydromyricetinFlavonolsAnti-Inflammatory AgentsToll-Like Receptor 4CytokinesNF-kappa BTlr4 protein, mouse

Autor:innen und Institutionen

  • The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, Hunan, 410008, China.
  • Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, Hunan, 410008, China.
  • The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. lanchen2008@163.com.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan, 410008, China. lanchen2008@163.com.
  • Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, Hunan, 410008, China. lanchen2008@163.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Li, R., Zhou, X., Mao, M., Chen, W., Zhu, W., & Chen, X. (2025). Dihydromyricetin alleviates imiquimod-induced psoriasiform inflammation by inhibiting M1 macrophage polarization. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-03905-9

Vancouver

Li R, Zhou X, Mao M, Chen W, Zhu W, Chen X. Dihydromyricetin alleviates imiquimod-induced psoriasiform inflammation by inhibiting M1 macrophage polarization. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-03905-9

BibTeX
@article{Li2025,
  author = {Li, Rao and Zhou, Xingchen and Mao, Manyun and Chen, Wangqing and Zhu, Wu and Chen, Xiang},
  title = {Dihydromyricetin alleviates imiquimod-induced psoriasiform inflammation by inhibiting M1 macrophage polarization},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-025-03905-9}
}
Kostenlos starten →